COVID-19 updates: US cases at lowest point since Christmas

Daily cases have dropped by 71% over the last three weeks.

Last Updated: February 14, 2022, 12:04 AM EST

As the COVID-19 pandemic has swept the globe, more than 5.8 million people have died from the disease worldwide, including over 919,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.

About 64.4% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.

Latest headlines:

Here's how the news is developing. All times Eastern.
Feb 11, 2022, 3:10 PM EST

Pfizer delays request for vaccine for kids under 5

Pfizer said it has postponed its application to the FDA to expand the use of its COVID-19 vaccine for kids under 5.

In this Nov. 12, 2021, file photo, a first grade student receives a COVID-19 vaccine at Arturo Velasquez Institute in Chicago.
Scott Olson/Getty Images, FILE

Pfizer instead will continue with its study on the three-dose vaccine and seek authorization when that data is available.

"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," Pfizer said.

Dr. Peter Marks, the FDA’s vaccine chief, told reporters Friday, “We realized now, in data that came in very rapidly because of the large number of cases of omicron, that at this time, it makes sense for us to wait until we have the data from the evaluation of a third dose before taking action."

Marks acknowledged that the change was “late breaking” -- the FDA’s committee of independent advisers was scheduled to review and vote on authorizing the vaccine next week -- but said the job of the FDA was to “adjust” to new data amid an unpredictable virus.

“The data that we saw made us realize that we needed to see data from a third dose as in the ongoing trial in order to make the term determination that we could proceed with doing an authorization,” Marks said.

Pfizer has predicted it will be able to submit data on the third dose in early April.

-ABC News' Eric M. Strauss, Cheyenne Haslett

Feb 11, 2022, 3:00 PM EST

FDA authorizes new monoclonal treatment that works against omicron 

The FDA has authorized a new monoclonal antibody treatment from Eli Lilly called bebtelovimab, an injection which has shown to hold up against omicron and the BA.2 subvariant. 

As with other monoclonal therapies, this is for COVID-19 patients early on in their infection who are at high risk for getting severely ill, to help keep them from getting sicker and help keep them out of the hospital. 

The Biden administration said it has purchased 600,000 doses for roughly $720 million in anticipation of bebtelovimab getting an emergency use authorization from the FDA. 

The plan is to get about 300,000 doses this month and another 300,000 in March. The contract also includes a future option for 500,000 more doses if necessary.  

-ABC News' Sasha Pezenik

Feb 11, 2022, 12:09 PM EST

US cases at lowest point since Christmas

The daily case average in the U.S. has dropped to its lowest point since Christmas, with the nation now reporting an average of 215,000 new cases each day -- a 71% drop in the last three weeks, according to federal data.

Restaurants re-open as people still wear their masks, amid the COVID-19 pandemic, in Los Angeles, Feb. 8, 2022.
David Swanson/Reuters

However, even with the declines, nearly 99% of U.S. counties are reporting high transmission. Also, many Americans are taking at-home tests and not submitting their results, so case totals may be higher than reported.

U.S. hospitalization rates are also declining.

On average, about 12,100 Americans are being admitted to the hospital with COVID-19 each day, down by about 25% in the last week, according to federal data.

The national average continues to plateau around 2,300 new COVID-19-related deaths per day.

-ABC News' Arielle Mitropoulos

Feb 11, 2022, 6:56 AM EST

New York City's unvaccinated workers face termination

About 3,000 municipal workers in New York City -- less than 1% of the city's workforce —- face termination Friday after refusing to abide by a COVID-19 vaccine mandate.

The requirement, established under former New York City Mayor Bill de Blasio, applies to municipal employees hired after Aug. 2, 2021, who were told to be vaccinated against COVID-19 as a condition of employment and to unvaccinated police officers, correction officers, firefighters and others who opted to forego city health benefits and are currently on leave because they are not vaccinated.

The mandate achieved a vaccination rate among municipal workers of more than 95%. A number of exceptions were approved in recent months.

New York City Mayor Eric Adams said Thursday that some workers initially facing termination had submitted their proof of vaccination, so the final number wasn't yet clear. He reiterated that the stragglers aren't being fired but are "quitting."

"The responsibility is clear," Adams told reporters Thursday. "We said it. If you were hired, you get this job, you have to be vaccinated. If you are not following the rules, you are making that decision. You are making the decision that you are not going to follow the rules of getting vaccinated. And that is a decision they are making."

"I want them to stay, I want them to be employees of the city," he added. "But they have to follow the rules."

-ABC News' Mark Crudele and Aaron Katersky

Related Topics